Selah Genomics Completes MBO

Selah Genomics has completed the management buyout of Lab21 Inc, the US subsidiary of Lab21 Ltd, led by the existing Lab21 Inc management team. Nexus Medical Partners, SCRA Technology Ventures` Stage 2 Affiliate, SC Launch and the Greenville Local Development Corporation supported the buyout.

DealsNorth AmericaUSBriefs